Opus Genetics, Inc.
IRD
$3.61
-$0.11-2.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.10M | -65.54M | -16.52M | -17.45M | -7.42M |
| Total Depreciation and Amortization | 14.00K | 13.00K | 13.00K | 13.00K | 14.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.86M | 52.90M | 6.60M | 10.41M | -55.00K |
| Change in Net Operating Assets | 995.00K | -102.00K | 73.00K | 875.00K | -2.81M |
| Cash from Operations | -11.95M | -12.73M | -9.83M | -6.16M | -10.27M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 35.00M | -- | 0.00 | 0.00 | 1.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.15M | 2.99M | 24.32M | 5.24M | 0.00 |
| Repurchase of Common Stock | 0.00 | -33.00K | -116.00K | 0.00 | 0.00 |
| Issuance of Preferred Stock | 0.00 | 25.00M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.24M | -360.00K | -98.00K | -696.00K | -94.00K |
| Cash from Financing | 40.90M | 27.60M | 24.11M | 4.54M | 906.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.95M | 14.87M | 14.28M | -1.61M | -9.36M |